CN115590191B - Quaternary complex microcapsule carrying enriched omega 3 fatty acid and preparation method thereof - Google Patents
Quaternary complex microcapsule carrying enriched omega 3 fatty acid and preparation method thereof Download PDFInfo
- Publication number
- CN115590191B CN115590191B CN202211226748.4A CN202211226748A CN115590191B CN 115590191 B CN115590191 B CN 115590191B CN 202211226748 A CN202211226748 A CN 202211226748A CN 115590191 B CN115590191 B CN 115590191B
- Authority
- CN
- China
- Prior art keywords
- microcapsule
- microcapsules
- quaternary
- oil
- wall material
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 239000003094 microcapsule Substances 0.000 title claims abstract description 210
- 235000020660 omega-3 fatty acid Nutrition 0.000 title claims abstract description 32
- 229940012843 omega-3 fatty acid Drugs 0.000 title claims abstract description 31
- CYQFCXCEBYINGO-IAGOWNOFSA-N delta1-THC Chemical compound C1=C(C)CC[C@H]2C(C)(C)OC3=CC(CCCCC)=CC(O)=C3[C@@H]21 CYQFCXCEBYINGO-IAGOWNOFSA-N 0.000 title claims abstract description 23
- 238000002360 preparation method Methods 0.000 title abstract description 17
- 239000000463 material Substances 0.000 claims abstract description 75
- 150000001875 compounds Chemical class 0.000 claims abstract description 52
- 239000011162 core material Substances 0.000 claims abstract description 47
- VFLDPWHFBUODDF-FCXRPNKRSA-N curcumin Chemical group C1=C(O)C(OC)=CC(\C=C\C(=O)CC(=O)\C=C\C=2C=C(OC)C(O)=CC=2)=C1 VFLDPWHFBUODDF-FCXRPNKRSA-N 0.000 claims abstract description 46
- 229940109262 curcumin Drugs 0.000 claims abstract description 39
- 239000004148 curcumin Substances 0.000 claims abstract description 25
- 235000012754 curcumin Nutrition 0.000 claims abstract description 23
- VFLDPWHFBUODDF-UHFFFAOYSA-N diferuloylmethane Natural products C1=C(O)C(OC)=CC(C=CC(=O)CC(=O)C=CC=2C=C(OC)C(O)=CC=2)=C1 VFLDPWHFBUODDF-UHFFFAOYSA-N 0.000 claims abstract description 23
- 239000000203 mixture Substances 0.000 claims abstract description 18
- 102000004407 Lactalbumin Human genes 0.000 claims abstract description 17
- 108090000942 Lactalbumin Proteins 0.000 claims abstract description 17
- 239000005913 Maltodextrin Substances 0.000 claims abstract description 17
- 229920002774 Maltodextrin Polymers 0.000 claims abstract description 17
- 229940035034 maltodextrin Drugs 0.000 claims abstract description 17
- 229940071440 soy protein isolate Drugs 0.000 claims abstract description 16
- 235000021241 α-lactalbumin Nutrition 0.000 claims abstract description 16
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 15
- 239000003921 oil Substances 0.000 claims description 59
- 239000011219 quaternary composite Substances 0.000 claims description 25
- 238000000034 method Methods 0.000 claims description 24
- 238000001694 spray drying Methods 0.000 claims description 16
- 239000000839 emulsion Substances 0.000 claims description 15
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 12
- 238000003756 stirring Methods 0.000 claims description 12
- 238000002156 mixing Methods 0.000 claims description 9
- 239000006014 omega-3 oil Substances 0.000 claims description 8
- 238000010008 shearing Methods 0.000 claims description 6
- 238000000265 homogenisation Methods 0.000 claims description 3
- 238000004519 manufacturing process Methods 0.000 claims 1
- 235000019198 oils Nutrition 0.000 abstract description 62
- 241000736199 Paeonia Species 0.000 abstract description 25
- 235000006484 Paeonia officinalis Nutrition 0.000 abstract description 25
- 235000015112 vegetable and seed oil Nutrition 0.000 abstract description 21
- 235000021323 fish oil Nutrition 0.000 abstract description 19
- 229940001941 soy protein Drugs 0.000 abstract description 9
- 230000036541 health Effects 0.000 abstract description 5
- 241000736029 Ruvettus pretiosus Species 0.000 abstract description 4
- 239000002994 raw material Substances 0.000 abstract description 4
- 230000000050 nutritive effect Effects 0.000 abstract description 3
- 230000000694 effects Effects 0.000 description 24
- 239000002245 particle Substances 0.000 description 23
- 239000002131 composite material Substances 0.000 description 21
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 20
- 238000009826 distribution Methods 0.000 description 16
- 238000012360 testing method Methods 0.000 description 16
- DTOSIQBPPRVQHS-PDBXOOCHSA-N alpha-linolenic acid Chemical compound CC\C=C/C\C=C/C\C=C/CCCCCCCC(O)=O DTOSIQBPPRVQHS-PDBXOOCHSA-N 0.000 description 15
- 239000011206 ternary composite Substances 0.000 description 13
- 238000003860 storage Methods 0.000 description 11
- 229920001282 polysaccharide Polymers 0.000 description 9
- 239000005017 polysaccharide Substances 0.000 description 9
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 8
- 235000014113 dietary fatty acids Nutrition 0.000 description 8
- 229930195729 fatty acid Natural products 0.000 description 8
- 239000000194 fatty acid Substances 0.000 description 8
- 150000004665 fatty acids Chemical class 0.000 description 8
- 239000004519 grease Substances 0.000 description 8
- 238000005259 measurement Methods 0.000 description 8
- 239000000047 product Substances 0.000 description 8
- 238000004458 analytical method Methods 0.000 description 7
- 238000010586 diagram Methods 0.000 description 7
- 238000005538 encapsulation Methods 0.000 description 7
- 230000008569 process Effects 0.000 description 7
- 230000004044 response Effects 0.000 description 7
- MBMBGCFOFBJSGT-KUBAVDMBSA-N docosahexaenoic acid Natural products CC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CCC(O)=O MBMBGCFOFBJSGT-KUBAVDMBSA-N 0.000 description 6
- 235000020777 polyunsaturated fatty acids Nutrition 0.000 description 6
- 239000000843 powder Substances 0.000 description 6
- 230000002292 Radical scavenging effect Effects 0.000 description 5
- 238000002441 X-ray diffraction Methods 0.000 description 5
- 238000010521 absorption reaction Methods 0.000 description 5
- 239000011218 binary composite Substances 0.000 description 5
- MGJZITXUQXWAKY-UHFFFAOYSA-N diphenyl-(2,4,6-trinitrophenyl)iminoazanium Chemical compound [O-][N+](=O)C1=CC([N+](=O)[O-])=CC([N+]([O-])=O)=C1N=[N+](C=1C=CC=CC=1)C1=CC=CC=C1 MGJZITXUQXWAKY-UHFFFAOYSA-N 0.000 description 5
- 235000020669 docosahexaenoic acid Nutrition 0.000 description 5
- 238000001035 drying Methods 0.000 description 5
- 235000020673 eicosapentaenoic acid Nutrition 0.000 description 5
- 238000011156 evaluation Methods 0.000 description 5
- 238000002347 injection Methods 0.000 description 5
- 239000007924 injection Substances 0.000 description 5
- 239000000243 solution Substances 0.000 description 5
- 239000000679 carrageenan Substances 0.000 description 4
- 229920001525 carrageenan Polymers 0.000 description 4
- 229940113118 carrageenan Drugs 0.000 description 4
- 230000008859 change Effects 0.000 description 4
- 238000001816 cooling Methods 0.000 description 4
- 230000007423 decrease Effects 0.000 description 4
- 238000005516 engineering process Methods 0.000 description 4
- 150000004676 glycans Chemical class 0.000 description 4
- 238000002329 infrared spectrum Methods 0.000 description 4
- 238000001000 micrograph Methods 0.000 description 4
- 229910052757 nitrogen Inorganic materials 0.000 description 4
- 230000003647 oxidation Effects 0.000 description 4
- 238000007254 oxidation reaction Methods 0.000 description 4
- 230000001603 reducing effect Effects 0.000 description 4
- 239000000126 substance Substances 0.000 description 4
- 238000005303 weighing Methods 0.000 description 4
- LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 description 3
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 3
- 108010073771 Soybean Proteins Proteins 0.000 description 3
- 238000000540 analysis of variance Methods 0.000 description 3
- 230000015572 biosynthetic process Effects 0.000 description 3
- 238000005336 cracking Methods 0.000 description 3
- 238000013461 design Methods 0.000 description 3
- 238000001514 detection method Methods 0.000 description 3
- 238000001704 evaporation Methods 0.000 description 3
- 238000000605 extraction Methods 0.000 description 3
- 235000013305 food Nutrition 0.000 description 3
- 239000007789 gas Substances 0.000 description 3
- 230000009477 glass transition Effects 0.000 description 3
- 238000004128 high performance liquid chromatography Methods 0.000 description 3
- KQQKGWQCNNTQJW-UHFFFAOYSA-N linolenic acid Natural products CC=CCCC=CCC=CCCCCCCCC(O)=O KQQKGWQCNNTQJW-UHFFFAOYSA-N 0.000 description 3
- 239000007788 liquid Substances 0.000 description 3
- 238000004949 mass spectrometry Methods 0.000 description 3
- 238000002844 melting Methods 0.000 description 3
- 230000008018 melting Effects 0.000 description 3
- 230000001590 oxidative effect Effects 0.000 description 3
- 150000002978 peroxides Chemical class 0.000 description 3
- 239000003208 petroleum Substances 0.000 description 3
- 238000011160 research Methods 0.000 description 3
- 239000006228 supernatant Substances 0.000 description 3
- 235000021122 unsaturated fatty acids Nutrition 0.000 description 3
- 150000004670 unsaturated fatty acids Chemical class 0.000 description 3
- WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 description 2
- QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 description 2
- 229920001661 Chitosan Polymers 0.000 description 2
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
- 238000005033 Fourier transform infrared spectroscopy Methods 0.000 description 2
- 229920002581 Glucomannan Polymers 0.000 description 2
- 241000282412 Homo Species 0.000 description 2
- 239000005642 Oleic acid Substances 0.000 description 2
- ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 description 2
- REFJWTPEDVJJIY-UHFFFAOYSA-N Quercetin Chemical compound C=1C(O)=CC(O)=C(C(C=2O)=O)C=1OC=2C1=CC=C(O)C(O)=C1 REFJWTPEDVJJIY-UHFFFAOYSA-N 0.000 description 2
- 235000020661 alpha-linolenic acid Nutrition 0.000 description 2
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 2
- -1 but no crack Substances 0.000 description 2
- 238000004364 calculation method Methods 0.000 description 2
- 239000002775 capsule Substances 0.000 description 2
- 235000010418 carrageenan Nutrition 0.000 description 2
- 238000002425 crystallisation Methods 0.000 description 2
- 230000008025 crystallization Effects 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- 230000018109 developmental process Effects 0.000 description 2
- UKMSUNONTOPOIO-UHFFFAOYSA-N docosanoic acid Chemical compound CCCCCCCCCCCCCCCCCCCCCC(O)=O UKMSUNONTOPOIO-UHFFFAOYSA-N 0.000 description 2
- 230000008020 evaporation Effects 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 229940046240 glucomannan Drugs 0.000 description 2
- 238000010438 heat treatment Methods 0.000 description 2
- IPCSVZSSVZVIGE-UHFFFAOYSA-N hexadecanoic acid Chemical compound CCCCCCCCCCCCCCCC(O)=O IPCSVZSSVZVIGE-UHFFFAOYSA-N 0.000 description 2
- VKOBVWXKNCXXDE-UHFFFAOYSA-N icosanoic acid Chemical compound CCCCCCCCCCCCCCCCCCCC(O)=O VKOBVWXKNCXXDE-UHFFFAOYSA-N 0.000 description 2
- 239000004615 ingredient Substances 0.000 description 2
- 150000002500 ions Chemical class 0.000 description 2
- QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 description 2
- OYHQOLUKZRVURQ-IXWMQOLASA-N linoleic acid Natural products CCCCC\C=C/C\C=C\CCCCCCCC(O)=O OYHQOLUKZRVURQ-IXWMQOLASA-N 0.000 description 2
- 229960004488 linolenic acid Drugs 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 235000021281 monounsaturated fatty acids Nutrition 0.000 description 2
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 2
- 230000007935 neutral effect Effects 0.000 description 2
- 235000014593 oils and fats Nutrition 0.000 description 2
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 2
- 239000001301 oxygen Substances 0.000 description 2
- 229910052760 oxygen Inorganic materials 0.000 description 2
- SECPZKHBENQXJG-FPLPWBNLSA-N palmitoleic acid Chemical compound CCCCCC\C=C/CCCCCCCC(O)=O SECPZKHBENQXJG-FPLPWBNLSA-N 0.000 description 2
- IOLCXVTUBQKXJR-UHFFFAOYSA-M potassium bromide Chemical compound [K+].[Br-] IOLCXVTUBQKXJR-UHFFFAOYSA-M 0.000 description 2
- 235000003441 saturated fatty acids Nutrition 0.000 description 2
- 150000004671 saturated fatty acids Chemical class 0.000 description 2
- 230000000087 stabilizing effect Effects 0.000 description 2
- UHVMMEOXYDMDKI-JKYCWFKZSA-L zinc;1-(5-cyanopyridin-2-yl)-3-[(1s,2s)-2-(6-fluoro-2-hydroxy-3-propanoylphenyl)cyclopropyl]urea;diacetate Chemical compound [Zn+2].CC([O-])=O.CC([O-])=O.CCC(=O)C1=CC=C(F)C([C@H]2[C@H](C2)NC(=O)NC=2N=CC(=CC=2)C#N)=C1O UHVMMEOXYDMDKI-JKYCWFKZSA-L 0.000 description 2
- BITHHVVYSMSWAG-KTKRTIGZSA-N (11Z)-icos-11-enoic acid Chemical compound CCCCCCCC\C=C/CCCCCCCCCC(O)=O BITHHVVYSMSWAG-KTKRTIGZSA-N 0.000 description 1
- MJYQFWSXKFLTAY-OVEQLNGDSA-N (2r,3r)-2,3-bis[(4-hydroxy-3-methoxyphenyl)methyl]butane-1,4-diol;(2r,3r,4s,5s,6r)-6-(hydroxymethyl)oxane-2,3,4,5-tetrol Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O.C1=C(O)C(OC)=CC(C[C@@H](CO)[C@H](CO)CC=2C=C(OC)C(O)=CC=2)=C1 MJYQFWSXKFLTAY-OVEQLNGDSA-N 0.000 description 1
- LUEWUZLMQUOBSB-FSKGGBMCSA-N (2s,3s,4s,5s,6r)-2-[(2r,3s,4r,5r,6s)-6-[(2r,3s,4r,5s,6s)-4,5-dihydroxy-2-(hydroxymethyl)-6-[(2r,4r,5s,6r)-4,5,6-trihydroxy-2-(hydroxymethyl)oxan-3-yl]oxyoxan-3-yl]oxy-4,5-dihydroxy-2-(hydroxymethyl)oxan-3-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol Chemical compound O[C@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@@H](O[C@@H]2[C@H](O[C@@H](OC3[C@H](O[C@@H](O)[C@@H](O)[C@H]3O)CO)[C@@H](O)[C@H]2O)CO)[C@H](O)[C@H]1O LUEWUZLMQUOBSB-FSKGGBMCSA-N 0.000 description 1
- OYHQOLUKZRVURQ-NTGFUMLPSA-N (9Z,12Z)-9,10,12,13-tetratritiooctadeca-9,12-dienoic acid Chemical compound C(CCCCCCC\C(=C(/C\C(=C(/CCCCC)\[3H])\[3H])\[3H])\[3H])(=O)O OYHQOLUKZRVURQ-NTGFUMLPSA-N 0.000 description 1
- OYHQOLUKZRVURQ-UHFFFAOYSA-N 9,12-Octadecadienoic Acid Chemical compound CCCCCC=CCC=CCCCCCCCC(O)=O OYHQOLUKZRVURQ-UHFFFAOYSA-N 0.000 description 1
- VHUUQVKOLVNVRT-UHFFFAOYSA-N Ammonium hydroxide Chemical compound [NH4+].[OH-] VHUUQVKOLVNVRT-UHFFFAOYSA-N 0.000 description 1
- 208000023275 Autoimmune disease Diseases 0.000 description 1
- 235000021357 Behenic acid Nutrition 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical group [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- 208000024172 Cardiovascular disease Diseases 0.000 description 1
- 241000272194 Ciconiiformes Species 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 1
- NHTMVDHEPJAVLT-UHFFFAOYSA-N Isooctane Chemical compound CC(C)CC(C)(C)C NHTMVDHEPJAVLT-UHFFFAOYSA-N 0.000 description 1
- OYHQOLUKZRVURQ-HZJYTTRNSA-N Linoleic acid Chemical compound CCCCC\C=C/C\C=C/CCCCCCCC(O)=O OYHQOLUKZRVURQ-HZJYTTRNSA-N 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 235000021314 Palmitic acid Nutrition 0.000 description 1
- 235000021319 Palmitoleic acid Nutrition 0.000 description 1
- ZVOLCUVKHLEPEV-UHFFFAOYSA-N Quercetagetin Natural products C1=C(O)C(O)=CC=C1C1=C(O)C(=O)C2=C(O)C(O)=C(O)C=C2O1 ZVOLCUVKHLEPEV-UHFFFAOYSA-N 0.000 description 1
- HWTZYBCRDDUBJY-UHFFFAOYSA-N Rhynchosin Natural products C1=C(O)C(O)=CC=C1C1=C(O)C(=O)C2=CC(O)=C(O)C=C2O1 HWTZYBCRDDUBJY-UHFFFAOYSA-N 0.000 description 1
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 1
- 244000272459 Silybum marianum Species 0.000 description 1
- 235000010841 Silybum marianum Nutrition 0.000 description 1
- 235000021355 Stearic acid Nutrition 0.000 description 1
- 238000002479 acid--base titration Methods 0.000 description 1
- JAZBEHYOTPTENJ-JLNKQSITSA-N all-cis-5,8,11,14,17-icosapentaenoic acid Chemical compound CC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CCCC(O)=O JAZBEHYOTPTENJ-JLNKQSITSA-N 0.000 description 1
- OENHQHLEOONYIE-UKMVMLAPSA-N all-trans beta-carotene Natural products CC=1CCCC(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C OENHQHLEOONYIE-UKMVMLAPSA-N 0.000 description 1
- 235000011114 ammonium hydroxide Nutrition 0.000 description 1
- 239000012491 analyte Substances 0.000 description 1
- 230000003064 anti-oxidating effect Effects 0.000 description 1
- 238000000889 atomisation Methods 0.000 description 1
- 229940116226 behenic acid Drugs 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 235000013734 beta-carotene Nutrition 0.000 description 1
- 239000011648 beta-carotene Substances 0.000 description 1
- TUPZEYHYWIEDIH-WAIFQNFQSA-N beta-carotene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCCC1(C)C)C=CC=C(/C)C=CC2=CCCCC2(C)C TUPZEYHYWIEDIH-WAIFQNFQSA-N 0.000 description 1
- 229960002747 betacarotene Drugs 0.000 description 1
- 229920001222 biopolymer Polymers 0.000 description 1
- 230000000903 blocking effect Effects 0.000 description 1
- 230000004641 brain development Effects 0.000 description 1
- 230000036995 brain health Effects 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 125000002057 carboxymethyl group Chemical group [H]OC(=O)C([H])([H])[*] 0.000 description 1
- 239000000969 carrier Substances 0.000 description 1
- 239000012159 carrier gas Substances 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- SECPZKHBENQXJG-UHFFFAOYSA-N cis-palmitoleic acid Natural products CCCCCCC=CCCCCCCCC(O)=O SECPZKHBENQXJG-UHFFFAOYSA-N 0.000 description 1
- 239000000084 colloidal system Substances 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 108010011713 delta-15 desaturase Proteins 0.000 description 1
- 238000001212 derivatisation Methods 0.000 description 1
- 230000006866 deterioration Effects 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 238000000113 differential scanning calorimetry Methods 0.000 description 1
- 238000001938 differential scanning calorimetry curve Methods 0.000 description 1
- 235000019621 digestibility Nutrition 0.000 description 1
- 238000007865 diluting Methods 0.000 description 1
- JVSWJIKNEAIKJW-UHFFFAOYSA-N dimethyl-hexane Natural products CCCCCC(C)C JVSWJIKNEAIKJW-UHFFFAOYSA-N 0.000 description 1
- 238000007599 discharging Methods 0.000 description 1
- 238000006073 displacement reaction Methods 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 229940090949 docosahexaenoic acid Drugs 0.000 description 1
- HHEAADYXPMHMCT-UHFFFAOYSA-N dpph Chemical compound [O-][N+](=O)C1=CC([N+](=O)[O-])=CC([N+]([O-])=O)=C1[N]N(C=1C=CC=CC=1)C1=CC=CC=C1 HHEAADYXPMHMCT-UHFFFAOYSA-N 0.000 description 1
- 229960005135 eicosapentaenoic acid Drugs 0.000 description 1
- JAZBEHYOTPTENJ-UHFFFAOYSA-N eicosapentaenoic acid Natural products CCC=CCC=CCC=CCC=CCC=CCCCC(O)=O JAZBEHYOTPTENJ-UHFFFAOYSA-N 0.000 description 1
- 229940108623 eicosenoic acid Drugs 0.000 description 1
- BITHHVVYSMSWAG-UHFFFAOYSA-N eicosenoic acid Natural products CCCCCCCCC=CCCCCCCCCCC(O)=O BITHHVVYSMSWAG-UHFFFAOYSA-N 0.000 description 1
- 239000003995 emulsifying agent Substances 0.000 description 1
- 230000001804 emulsifying effect Effects 0.000 description 1
- 238000001125 extrusion Methods 0.000 description 1
- 239000003925 fat Substances 0.000 description 1
- 235000019197 fats Nutrition 0.000 description 1
- 235000004426 flaxseed Nutrition 0.000 description 1
- 239000006260 foam Substances 0.000 description 1
- 238000000227 grinding Methods 0.000 description 1
- 239000001307 helium Substances 0.000 description 1
- 229910052734 helium Inorganic materials 0.000 description 1
- SWQJXJOGLNCZEY-UHFFFAOYSA-N helium atom Chemical compound [He] SWQJXJOGLNCZEY-UHFFFAOYSA-N 0.000 description 1
- 230000002209 hydrophobic effect Effects 0.000 description 1
- MWDZOUNAPSSOEL-UHFFFAOYSA-N kaempferol Natural products OC1=C(C(=O)c2cc(O)cc(O)c2O1)c3ccc(O)cc3 MWDZOUNAPSSOEL-UHFFFAOYSA-N 0.000 description 1
- 235000020778 linoleic acid Nutrition 0.000 description 1
- 238000007443 liposuction Methods 0.000 description 1
- 235000020978 long-chain polyunsaturated fatty acids Nutrition 0.000 description 1
- 238000013178 mathematical model Methods 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 239000012022 methylating agents Substances 0.000 description 1
- 238000013508 migration Methods 0.000 description 1
- 230000005012 migration Effects 0.000 description 1
- 239000004570 mortar (masonry) Substances 0.000 description 1
- WQEPLUUGTLDZJY-UHFFFAOYSA-N n-Pentadecanoic acid Natural products CCCCCCCCCCCCCCC(O)=O WQEPLUUGTLDZJY-UHFFFAOYSA-N 0.000 description 1
- 230000004770 neurodegeneration Effects 0.000 description 1
- 208000015122 neurodegenerative disease Diseases 0.000 description 1
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 1
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 1
- 238000013433 optimization analysis Methods 0.000 description 1
- 238000012803 optimization experiment Methods 0.000 description 1
- 238000003921 particle size analysis Methods 0.000 description 1
- 239000001814 pectin Substances 0.000 description 1
- 229920001277 pectin Polymers 0.000 description 1
- 235000010987 pectin Nutrition 0.000 description 1
- 230000001766 physiological effect Effects 0.000 description 1
- 150000008442 polyphenolic compounds Chemical class 0.000 description 1
- 235000013824 polyphenols Nutrition 0.000 description 1
- 238000003825 pressing Methods 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 238000000164 protein isolation Methods 0.000 description 1
- 235000018102 proteins Nutrition 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 238000005173 quadrupole mass spectroscopy Methods 0.000 description 1
- 235000005875 quercetin Nutrition 0.000 description 1
- 229960001285 quercetin Drugs 0.000 description 1
- 230000000630 rising effect Effects 0.000 description 1
- 238000002390 rotary evaporation Methods 0.000 description 1
- 238000007789 sealing Methods 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 238000005507 spraying Methods 0.000 description 1
- 239000008117 stearic acid Substances 0.000 description 1
- 238000005211 surface analysis Methods 0.000 description 1
- 230000002277 temperature effect Effects 0.000 description 1
- TUNFSRHWOTWDNC-HKGQFRNVSA-N tetradecanoic acid Chemical compound CCCCCCCCCCCCC[14C](O)=O TUNFSRHWOTWDNC-HKGQFRNVSA-N 0.000 description 1
- 230000037303 wrinkles Effects 0.000 description 1
- DTOSIQBPPRVQHS-UHFFFAOYSA-N α-Linolenic acid Chemical compound CCC=CCC=CCC=CCCCCCCCC(O)=O DTOSIQBPPRVQHS-UHFFFAOYSA-N 0.000 description 1
- OENHQHLEOONYIE-JLTXGRSLSA-N β-Carotene Chemical compound CC=1CCCC(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C OENHQHLEOONYIE-JLTXGRSLSA-N 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/115—Fatty acids or derivatives thereof; Fats or oils
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/115—Fatty acids or derivatives thereof; Fats or oils
- A23L33/12—Fatty acids or derivatives thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/125—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives containing carbohydrate syrups; containing sugars; containing sugar alcohols; containing starch hydrolysates
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
- A23L33/185—Vegetable proteins
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
- A23L33/19—Dairy proteins
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23P—SHAPING OR WORKING OF FOODSTUFFS, NOT FULLY COVERED BY A SINGLE OTHER SUBCLASS
- A23P10/00—Shaping or working of foodstuffs characterised by the products
- A23P10/30—Encapsulation of particles, e.g. foodstuff additives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Abstract
The invention provides a quaternary compound microcapsule for carrying enriched omega 3 fatty acid and a preparation method thereof, wherein the quaternary compound microcapsule consists of a core material and a wall material, the core material is blend oil containing omega 3 fatty acid, and the wall material consists of a ternary compound and functional factors; the ternary complex consists of maltodextrin, soy protein isolate and alpha-lactalbumin; the functional factor is curcumin. The invention takes the quaternary compound formed by maltodextrin-soy protein isolate-alpha-lactalbumin-curcumin as a wall material, takes the blend oil of peony seed oil and fish oil as a core material, carries out compound embedding to prepare the quaternary compound microcapsule, analyzes the embedding rate, the water content, the solubility, the stability, the slow release property, the microstructure and other qualities of the microcapsule product so as to overcome the characteristic limitation, and obtains the peony seed oil-fish oil health care product and high-quality raw materials, wherein the peony seed oil-fish oil health care product is convenient to take, stable in property, good in fluidity and high in nutritive value.
Description
Technical Field
The invention relates to the technical field of microcapsule preparation, in particular to a quaternary compound microcapsule for carrying enriched omega 3 fatty acid and a preparation method thereof.
Background
Omega 3 polyunsaturated fatty acids, such as ALA, EPA, DHA, have great significance in the life and health process of human bodies, and are mainly reflected in the aspects of promoting brain development, maintaining brain health, reducing cardiovascular diseases, neurodegenerative diseases, autoimmune diseases, preventing and treating cancers and the like. However, due to the lack of Δ15-desaturase in humans, oleic acid cannot be converted to linoleic acid LA (9, 12-octadecadienoic acid, C) 18 H 32 O 2 ) Or linolenic acid ALA (9, 12, 15-octadecatrienoic acid, C 18 H 30 O 2 ) Thus limiting biosynthesis of long chain polyunsaturated fatty acids in humans.
Although human body can not autonomously synthesize ALA, EPA, DHA polyunsaturated fatty acids, many animals and plants have abundant polyunsaturated fatty acids, such as ALA in peony seed oil is more than 60% of its total unsaturated fatty acids, and deep sea fish oil contains a large amount of eicosapentaenoic acid (C 20 H 30 O 2 EPA) and docosahexaenoic acid (C) 22 H 30 O 2 Abbreviated as DHA) can be used as a source of polyunsaturated fatty acid raw materials. However, polyunsaturated fatty acids have a very strong reducing property containing a plurality of c=c bonds, and are susceptible to deterioration by light, heat and oxidizing substances. Therefore, the compound wall material is used for embedding the peony seed oil and the fish oil by adopting a microencapsulation technology, so that the effects of blocking oxygen, preventing light and heat can be achieved, and the bad smell brought by the fish oil can be covered.
The grease microcapsule is powdery particles formed by using a microcapsule technology, taking grease as a core material, taking substances with emulsifying properties such as carbohydrate or protein and the like as wall materials, adding a compounded small molecular emulsifier, homogenizing and spray drying. The wall material from which the microcapsules are built determines, among other things, their functional properties, such as stability, digestibility and release properties. Therefore, the choice of biopolymer wall materials with good physicochemical and physiological properties is critical for the preparation of microcapsules.
In recent years, numerous studies have shown that protein-polyphenol-polysaccharide non-covalent ternary complexes have many unique structural and functional properties compared to protein-polysaccharide and protein-polyphenol binary complexes. In one aspect, they can be effective carriers for hydrophilic or hydrophobic polyphenols. On the other hand, the non-covalent ternary complexes of protein-polyphenol-polysaccharide are considered novel wall materials for stabilizing emulsion, foam and colloid systems. To date, many protein-polyphenol-polysaccharide non-covalent ternary complexes have been successfully designed, such as soy isolate protein-quercetin-carrageenan, gelatin-tannic acid-glucomannan, gelatin-tannic acid-flaxseed gum, zein-tea polyphenol-carboxymethyl chitosan non-covalent complexes, and the like. For example, mao et al designed a non-covalent complex using soy protein isolate, carrageenan and quercetin, and ternary complexes were more effective in stabilizing beta-carotene emulsions than the soy protein isolate-carrageenan binary complex.
However, most polysaccharides used to prepare ternary protein-polyphenol-polysaccharide complexes other than glucomannan are ionic polysaccharides such as carrageenan, pectin, flaxseed gum, carboxymethyl chitosan, etc., and few reports are currently made on ternary/quaternary complex wall materials of neutral polysaccharides. Therefore, the invention aims to provide a quaternary complex microcapsule based on neutral polysaccharide, so as to improve the embedding rate, storage stability and slow release performance of the carried enriched omega 3 fatty acid, and provide data support for the development and utilization of omega 3 fatty acid in food.
Disclosure of Invention
In order to solve the problems, the invention aims to provide a quaternary composite microcapsule for carrying enriched omega 3 fatty acid and a preparation method thereof.
In order to achieve the above object, the technical scheme of the present invention is as follows.
The quaternary compound microcapsule for carrying the enriched omega 3 fatty acid consists of a core material and a wall material, wherein the core material is blend oil containing the omega 3 fatty acid, and the wall material consists of a ternary compound and a functional factor; the ternary complex consists of maltodextrin, soy protein isolate and alpha-lactalbumin; the functional factor is curcumin.
The invention also provides a preparation method of the quaternary compound microcapsule carrying enriched omega 3 fatty acid, which comprises the following steps:
s1, adding maltodextrin, soy protein isolate and alpha-lactalbumin into water at 50-55 ℃, stirring and mixing, adding a curcumin solution, continuously stirring and mixing, adding a core material, and uniformly stirring to obtain a primary emulsion;
s2, shearing and stirring the primary emulsion of the S1 at 50-55 ℃, then placing the primary emulsion in a high-pressure homogenizer for high-pressure homogenization treatment, and carrying out spray drying to obtain the quaternary composite microcapsule carrying the enriched omega 3 fatty acid.
Further, the mass ratio of the wall material to the core material is 5-7: 5.
further, in the ternary complex, the mass ratio of maltodextrin, soy protein isolate and alpha-lactalbumin is 1: 1-2: 1 to 3.
Further, the mass ratio of the ternary complex to curcumin is 30:0.01.
further, the curcumin solution is prepared by dissolving curcumin in ethanol; the dosage ratio of curcumin to ethanol is 0.01g: 4-6 mL.
In S2, shearing and stirring conditions are 8000-9600 r/min.
In S2, the high-pressure homogenization pressure is 30-35 Mpa.
Further, in S2, the conditions of spray drying are: the air inlet temperature is 160-180 ℃, and the feeding flow rate is 16-18 mL/min.
The invention has the beneficial effects that:
1. the invention takes the quaternary compound formed by maltodextrin-soy protein isolate-alpha-lactalbumin-curcumin as a wall material, takes the blend oil of peony seed oil and fish oil as a core material, carries out compound embedding to prepare the quaternary compound microcapsule, analyzes the embedding rate, the water content, the solubility, the stability, the slow release property, the microstructure and other qualities of the microcapsule product so as to overcome the characteristic limitation, and obtains the peony seed oil-fish oil health care product and high-quality raw materials, wherein the peony seed oil-fish oil health care product is convenient to take, stable in property, good in fluidity and high in nutritive value.
2. The invention takes peony seed oil and fish oil as raw materials, blends the peony seed oil and the fish oil according to a certain proportion, prepares composite oil which accords with the proportion of omega 3 fatty acids such as ALA, EPA, DHA and the like recommended by diet, forms quaternary composite microcapsules by adding functional factors curcumin, discusses the storage stability of the microcapsules, and provides data support for the development and utilization of omega 3 fatty acids in foods.
Drawings
FIG. 1 is a graph showing the effect of the ratio of the ternary complexes on the embedding rate.
FIG. 2 is a graph showing the effect of different wall core ratios on embedding rates.
FIG. 3 is a graph of the effect of inlet air temperature on the entrapment rate.
FIG. 4 is a graph of the effect of feed flow rate on entrapment rate.
FIG. 5 is a bar graph of the effect of different wall combinations on the encapsulation efficiency of microcapsules.
FIG. 6 is a bar graph of the effect of microcapsules of different wall material layers on the entrapment rate.
FIG. 7 is a microscopic image (100X) of microcapsules of different wall material layers. Wherein, (a) is a microscopic image of a binary complex microcapsule (α -la+ha); (b) Microscopic image of ternary complex microcapsules (spi+md+α -LA); (c) Microscopic image of quaternary complex microcapsules (spi+md+α -la+cur).
Fig. 8 is a Scanning Electron Microscope (SEM) image of the microcapsules. Wherein, (a) is a scanning electron microscope image with scanning electron microscope multiple of 1000x of ternary complex microcapsules (SPI+MD+alpha-LA); (b) Scanning electron microscope images with scanning electron microscope times of 4000x are obtained by adopting ternary composite microcapsules (SPI+MD+alpha-LA); (c) A scanning electron microscope image with the scanning electron microscope multiple of 1000x for the quaternary composite microcapsule (SPI+MD+alpha-LA+Cur); (d) Scanning electron microscope images with scanning electron microscope multiples of 4000x are obtained for the quaternary composite microcapsules (SPI+MD+alpha-LA+Cur).
FIG. 9 is a particle size distribution diagram of microcapsules. Wherein (a) is the particle size distribution diagram of the ternary complex microcapsule. (b) is a particle size distribution profile of the quaternary composite microcapsules.
FIG. 10 is a DSC of a microcapsule. Wherein (a) is a DSC of a ternary complex microcapsule. (b) is a DSC of a quaternary complex microcapsule.
FIG. 11 is an infrared spectrum of a microcapsule wall material.
Fig. 12 is an infrared spectrum of a microcapsule core material.
Fig. 13 is an infrared spectrum of ternary complex microcapsules (spi+md+α -LA) and quaternary complex microcapsules (spi+md+α -la+cur).
FIG. 14 is an X-ray diffraction pattern of microcapsules. Wherein a is an X-ray diffraction pattern diagram of ternary complex microcapsule (SPI+MD+alpha-LA); b is an X-ray diffraction pattern diagram of a quaternary composite microcapsule (SPI+MD+alpha-LA+Cur).
Fig. 15 is an HPLC diagram of the fatty acid composition of the compound oil before and after spray drying. Wherein a is an HPLC diagram of the fatty acid component of the compound oil before spray drying; b is an HPLC chart of the fatty acid component of the compound oil after spray drying.
Fig. 16 shows the change trend of POV values of the complex oil and the complex oil microcapsules at different temperatures.
FIG. 17 is the DPPH radical scavenging rate of ternary complex microcapsules (SPI+MD+α -LA) and quaternary complex microcapsules (SPI+MD+α -LA+Cur).
Detailed Description
The present invention will be described in further detail with reference to the drawings and examples, in order to make the objects, technical solutions and advantages of the present invention more apparent. It should be understood that the specific embodiments described herein are for purposes of illustration only and are not intended to limit the scope of the invention.
All other embodiments, which can be made by those skilled in the art based on the embodiments of the invention without making any inventive effort, are intended to be within the scope of the invention.
Experimental materials:
the peony seed oil and fish oil compound oil is prepared by mixing peony seed oil and fish oil according to a ratio of 2:1 (w/w) and mixing.
The methods described in the examples below are conventional, unless otherwise specified; the reagents and materials are commercially available unless otherwise specified.
Example 1
A quaternary compound microcapsule for carrying enriched omega 3 fatty acid comprises a core material and a wall material, wherein the core material is peony seed oil and fish oil compound oil, and the wall material comprises a ternary compound and a functional factor; the ternary complex consists of maltodextrin, soy protein isolate and alpha-lactalbumin; the functional factor is curcumin.
The preparation method of the quaternary compound microcapsule carrying enriched omega 3 fatty acid comprises the following steps:
s1, maltodextrin, soy protein isolate and alpha-lactalbumin are mixed according to a mass ratio of 1:1:1 is added into water with the temperature of 50-55 ℃ and stirred for 1.5 hours, then curcumin solution (curcumin and ethanol are prepared according to the weight ratio of 0.01g: 4-6 mL) is added, and the mass ratio of ternary complex to curcumin is 30:0.01, stirring for 30min, and after full dissolution, mixing according to the mass ratio of wall material to core material of 6:5, adding the core material, and fully stirring for 30min to obtain a primary emulsion;
s2, shearing the primary emulsion of S1 at 50-55 ℃ for 2min at 8000-9600 r/min by a high-speed shearing machine, and homogenizing twice by a high-pressure homogenizer at 30-35 Mpa to obtain a prepared microcapsule emulsion;
s3, spray-drying the microcapsule emulsion of S2 at the temperature of an air inlet of 170 ℃ and the feeding flow rate of 17mL/min to prepare microcapsule powder.
Example 2
According to the preparation method of the quaternary compound microcapsule carrying the enriched omega 3 fatty acid in the method of the embodiment 1, single factor tests are carried out according to different proportions of ternary compounds, so as to explore the influence of the proportions of the different ternary compounds on the embedding rate.
Maltodextrin, SPI and alpha-LA are used as ternary complexes, the proportions among the ternary complexes are selected to be 1:4:1, 1:3:2, 1:1:1, 1:2:3 and 1:1:4 (w/w), microencapsulation treatment is carried out on the peony seed oil and fish oil compound oil, the embedding rate is used as an evaluation index, a single factor test is carried out, and the proportion range among wall materials is selected. The curves of the influence of the mixture ratio of different ternary complexes on the embedding rate are shown in figure 1.
Example 3
According to the preparation method of the quaternary composite microcapsule carrying the enriched omega 3 fatty acid in the method of the embodiment 1, single factor tests are carried out according to different ratios of wall materials to core materials (called wall core ratio for short) so as to explore the influence of different wall core ratios on the embedding rate.
The ternary compound and curcumin are used as wall materials, the ratio of the ternary compound is the optimal ratio of the embodiment 2, the peony seed oil and fish oil compound oil is used as a core material, the wall-core ratio is selected to be 3:5, 4:5, 5:5, 6:5 and 7:5 respectively, the compound oil is subjected to microencapsulation treatment, the embedding rate is used as an evaluation index, and a single factor test is carried out to select the wall-core ratio range. The curves of the effect of different wall core ratios on the embedding rate are shown in fig. 2.
Example 4
The method of preparation of quaternary complex microcapsules carrying enriched omega 3 fatty acids was performed as described in example 1, using the inlet air temperature as a single factor test to investigate the effect of inlet air temperature on the entrapment rate.
The wall-core ratio was the optimum ratio in example 3, the air inlet temperature was selected to be 150℃and 160℃and 170℃and 180℃and 190℃respectively, the composite oil was subjected to microencapsulation treatment, and a single factor test was performed using the embedding rate as an evaluation index to select the air inlet temperature range. The curve of the air inlet temperature effect on the embedding rate is shown in fig. 3.
Example 5
The preparation of quaternary complex microcapsules carrying enriched omega 3 fatty acids was carried out as described in example 1, using a single factor test with feed flow rate to investigate the effect of feed flow rate on the entrapment rate.
The wall-core ratio is the optimal ratio of example 3, the air inlet temperature is the optimal temperature of example 4, the feeding flow rates are selected to be respectively 11mL/min, 14mL/min, 17mL/min, 20mL/min and 23mL/min, the composite oil is subjected to microencapsulation treatment, the embedding rate is used as an evaluation index, a single factor test is carried out, and the feeding flow rate range is selected. The curve of the feed flow rate versus the embedding rate is shown in fig. 4.
Example 6
Four-factor three-level response surface optimization experiments were performed on the preparation of quaternary complex microcapsules carrying enriched omega 3 fatty acids according to the method of example 1.
On the basis of a single factor experiment, four factors of ternary complex mixture ratio (maltodextrin: soy protein isolate: alpha-lactalbumin), wall core ratio, air inlet temperature and sample injection flow rate are selected for researching the comprehensive effect among different factors, and the optimal condition of the microcapsule preparation process is researched by taking the embedding rate as an evaluation index. The test used a 4 factor 3 horizontal response surface test, with factors and horizontal designs as shown in Table 1.
TABLE 1 factor and level analysis
Wherein A is ternary complex mixture ratio (maltodextrin: soy protein isolate: alpha-lactalbumin); b is the wall-core ratio; c is the temperature of the air inlet and is at the temperature of DEG C; d is the sample injection flow rate, mL/min.
Example 7
The microcapsule for carrying enriched omega 3 fatty acid consists of a core material and wall materials, wherein the core material is peony seed oil and fish oil compound oil, the influence of different wall material combinations on the embedding rate of the microcapsule is studied, and the specific wall material combinations are shown in Table 2. The specific preparation method was substantially the same as that of example 1. A bar graph of the effect of different wall material combinations on the microcapsule entrapment rate is shown in fig. 5.
TABLE 2 analysis of combinations of different wall materials
The process conditions for preparing microcapsules of examples 1 to 7 are examined below.
1. Detection of the encapsulation efficiency of microcapsules
1.1 method for measuring the embedding Rate of microcapsules
1.1.1 determination of microcapsule surface oil
Weigh m 0 The microcapsule sample was put in a dry conical flask, gently washed with 30mL petroleum ether and filtered to a dry rotary evaporation flask m 1 . Evaporating the solvent by rotary evaporator, and placing into a 60 deg.C drying oven to constant weight m 2 . Each sample was assayed in 3 replicates.
The calculation formula of the microcapsule surface oil is as follows:
1.1.2 determination of the Total oil content of microcapsules
Accurately weighing 0.5g of peony seed oil microcapsule, dissolving 20mL of peony seed oil microcapsule in a liposuction bottle with water at the temperature of 60 ℃, adding 2.5mL of ammonia water, fully and uniformly mixing, heating in a water bath at the temperature of 60 ℃ for 5min, shaking for 2min, adding 20mL of ethanol, fully and uniformly shaking, cooling in cold water, adding 50mL of diethyl ether, shaking for 0.5min, adding 50mL of petroleum ether sample, shaking for 0.5min, standing for 30min, clarifying the supernatant, reading the volume of an ether layer, discharging a certain volume of ether layer into a flask with known constant weight, distilling and recovering diethyl ether and petroleum ether, drying in an oven at the temperature of 105 ℃ for 1.5h, taking out, cooling to room temperature in a dryer, and weighing to obtain the total oil in the microcapsule. Three replicates were run for each sample.
Wherein M is 2 Beaker and fat mass, g; m is M 1 The quality of an empty beaker, g; m is M 0 Indicating the microcapsules weighedG, mass of (a); v represents the total volume of the read ether layer, g; v (V) 1 The ether layer volume, mL, was taken out.
1.1.3 data processing and statistics
Test data were analyzed using software Origin 9.0 and Design Expert 8.0.0. Each sample was assayed in triplicate, data expressed as mean ± standard deviation, and significance analysis was performed using ANOVA, with significant water P <0.05 indicating significant differences, and P <0.01 indicating very significant differences.
1.2 influence of the ratio between ternary complexes on the encapsulation efficiency of microcapsules
Ternary complexes (maltodextrin-soy protein isolate-alpha-lactalbumin) can affect the entrapment rate of oils by affecting the stability of the microcapsule emulsion and the moldability at spray drying.
FIG. 1 is a graph showing the effect of the ratio of the ternary complexes on the embedding rate. As can be seen from fig. 1, when the amount of maltodextrin is constant, but as the soy protein is isolated: the ratio of alpha-lactalbumin increases and the entrapment rate of the microcapsules increases, but when the soy protein isolate: when the ratio of alpha-lactalbumin reaches 1, the maximum entrapment rate is reached, followed by soy protein isolation: the ratio of alpha-lactalbumin continues to increase, and the embedding rate of microcapsules instead tends to decrease continuously. This shows that the ratio of ternary composite wall materials has a certain effect on the embedding rate of the microcapsules. Thus, it can be determined from FIG. 1 that the ratio of the optimal ternary complex (maltodextrin-soy protein isolate-alpha-lactalbumin) is 1:1:1 (w/w/w).
1.3 Effect of wall core ratio on microcapsule embedding Rate
FIG. 2 is a graph showing the effect of different wall core ratios on embedding rates. As can be seen from fig. 2, as the relative content of the wall material increases, the embedding rate of the microcapsule also increases, mainly because the wall material provides more structural space for the core material, and the thickness of the wall material forming a film in the spray drying process also increases accordingly, so that the loss of the core material can be more effectively suppressed, thereby reducing the loss of the core material. However, when the wall-core ratio is greater than 6:5, the embedding rate of the microcapsules is rather reduced, probably because too high a wall material content fails to form a film in time in the spray drying process, so that the microcapsules release a part of the capsule cores, causing loss of the core materials and reducing the embedding rate. The final wall to core ratio for this experiment was therefore 6:5 (w/w).
1.4 influence of air inlet temperature on microcapsule embedding rate
As shown in figure 3, in the range of 150-170 ℃, the embedding rate of the microcapsule gradually increases along with the temperature rise, the embedding rate is highest when the temperature of the air inlet is 170 ℃, and as the temperature continues to rise, the surface of the microcapsule is hardened and cracked due to higher temperature and faster evaporation of water in the drying process of the microcapsule, so that the embedding rate of the microcapsule is seriously influenced. Therefore, the temperature of the inlet air is controlled within 160-180 ℃.
1.5 influence of feed flow Rate on the encapsulation efficiency of microcapsules
As shown in fig. 4, as the feeding amount increases, the embedding rate of the microcapsules also increases, and reaches the maximum embedding rate at 17mL/min, at this time, the feeding amount continues to increase, and the embedding rate of the microcapsules decreases instead, because the feeding amount is too large, the temperature of the air outlet decreases, the moisture in the product fails to be dried in time, the wall sticking phenomenon is serious, the powder yield is low, and the embedding rate is further affected. Thus, the optimal feed flow rate was 17mL/min.
1.6 response surface method optimization analysis
On the basis of a single factor test, 3 levels which have obvious influence on the microcapsule embedding rate in 4 single factors are respectively selected for a response surface test. Response surface analysis schemes and experimental results are shown in Table 3, and analysis of variance is shown in Table 4.
TABLE 3 response surface test design and results
TABLE 4 analysis of variance and significance test of regression models
Note that: ". Times." indicates that the difference is very significant (P < 0.05); "x" indicates significant difference (P < 0.01). Wherein A is ternary complex mixture ratio (maltodextrin: soy protein isolate: alpha-lactalbumin); b is the wall-core ratio; c is the temperature of the air inlet and is at the temperature of DEG C; d is the sample injection flow rate, mL/min.
As can be seen from tables 3 to 4, the determination coefficient R of the model 2 0.8824, which indicates that the correlation of the model is very good, the model adjustment coefficient R 2 0.7648, which shows that the model can interpret 76.48% response change, model mismatch term p= 0.0721>0.05, which indicates that the model is better in significance. Therefore, the embedding rate of the microcapsule under different ingredient ratios in the microcapsule preparation process can be predicted and analyzed according to the mathematical model, and a new formula process is designed in an aided manner. Fitting a regression equation: embedding rate = +90.38-7.88 a+2.74 b-1.83+0.037 b+2.37 a b-2.43 a c+1.17 a d-5.02 b c+0.88 b d+1.72 c d-12.64 a 2-13.97 b 2-2.08 c 2-4.60 d 2. Wherein the A, A A2 and B2 terms are factors that affect the significance of the factors (P<0.01 The D2 term is a factor that affects significance (P<0.05 As can be seen from this, the order of magnitude of the effect on the microcapsule entrapment rate is: proportioning between wall materials>Wall to core ratio>Air inlet temperature>Feed flow rate.
1.7 influence of wall Material on the encapsulation efficiency of microcapsules
1.7.1 influence of wall Material combinations on the encapsulation efficiency of microcapsules
As can be seen from fig. 5, the entrapment rate of the grease microcapsule prepared by the binary composite wall material of the combination of maltodextrin, soy protein isolate and maltodextrin and lactalbumin is relatively high. However, in general, the microcapsule prepared from the ternary composite wall material and the quaternary composite wall material has a higher embedding rate than the grease microcapsule prepared from the binary composite wall material, wherein the microcapsule prepared from the quaternary composite wall material shows a relatively higher embedding effect.
1.7.2 influence of the number of wall Material layers on the encapsulation efficiency of the microcapsules
Different wall material combinations can influence the embedding rate of grease by influencing the embedding effect on the microcapsule core material and the film forming property during spray drying. The microcapsule prepared by the binary composite wall material (SPI+MD) is marked as a binary composite microcapsule; the microcapsules prepared by ternary composite wall materials (SPI+MD+alpha-LA) are marked as ternary composite microcapsules; the microcapsules prepared by the four-component composite wall material (SPI+MD+alpha-LA+Cur) are marked as four-component composite microcapsules.
As can be seen from table 2 and fig. 6, the entrapment rate of the quaternary compound microcapsules and ternary compound microcapsules was higher than that of the binary compound microcapsules. This is probably because the ternary and quaternary complexes provide more hollow structure for the core grease, making the grease droplets easier to embed. Wherein, the quaternary compound microcapsule has higher embedding effect.
FIG. 7 is a microstructure of microcapsules of different wall material layers. Wherein (a) is a microscopic image of microcapsules prepared from binary composite wall material (α -la+ha); (b) Microscopic image of microcapsules prepared for ternary composite wall material (α -la+md+spi); (c) Microscopic image of microcapsules prepared for quaternary composite wall material (spi+md+α -la+cur).
As can be seen from fig. 7, the microcapsule prepared from the α -la+ha composite wall material in fig. 7 (a) HAs a good morphology, is completely free of wall breaking, but cannot completely and effectively embed oil droplets, so that a part of the oil droplets are exposed to the outside. Fig. 7 (b) microcapsules made of an α -la+md+spi composite wall material and fig. 7 (c) microcapsules made of an α -la+md+spi+cur composite wall material are uniform in morphology and fully encapsulate oil droplets effectively.
2. Research on physicochemical properties of microcapsules
2.1 SEM Structure observations of microcapsules
A certain amount of omega 3 fatty acid microcapsules were sprinkled on a sample stage with double sided tape attached, excess microcapsule powder was blown off, and a metal spraying treatment was performed, and structural observation of the microcapsules was performed by SEM.
Fig. 8 is a Scanning Electron Microscope (SEM) of the microcapsules. Wherein (a) and (b) are microcapsules prepared from ternary complex wall material (α -la+md+spi), denoted ternary complex microcapsules; (c) And (d) microcapsules prepared with a quaternary composite wall material (α -la+md+spi+cur) are denoted quaternary composite microcapsules.
As can be seen from fig. 8, the product appearance of the quaternary composite microcapsule is spherical, and the particle size and the morphology distribution are relatively uniform. The surface of the capsule wall particles of the ternary composite microcapsule has the phenomenon of wrinkling and recessing, and some tiny particles are attached to the surface of large particles, but no crack, hole or fracture phenomenon occurs, which is probably caused by mutual extrusion and adhesion of liquid drops in the atomization process; it is also possible that the wall material shrinks and depressions or wrinkles are generated due to the surface tension of the droplets and the migration of the droplets during the drying process, especially during the cooling phase if the curing of the microcapsule wall material is preceded by expansion by the hot gas flow.
Compared with the microscopic morphology of the ternary complex microcapsule, the quaternary complex microcapsule added with curcumin has smoother surface, which possibly has a certain relation with the structural modification of curcumin.
2.2 determination of particle size distribution of microcapsules
Diluting a microcapsule sample to be detected to a certain multiple, carrying out particle size analysis by using a laser particle size analyzer to obtain the particle size distribution of the microcapsule, and drawing a particle size distribution diagram. The particle size and the distribution of the microcapsules are important parameters of the microcapsule product. The particle size distribution of microcapsules prepared with ternary composite wall material (α -la+md+spi) (denoted as ternary composite microcapsules) is shown in fig. 9 (a). The particle size distribution of microcapsules prepared with quaternary composite wall material (α -la+md+spi+cur) (denoted as quaternary composite microcapsules) is shown in fig. 9 (b). The particle size content of the microcapsules is shown in Table 5.
TABLE 5 particle size content of microcapsules
As can be seen from the data of fig. 9 and table 5, the particle size distribution of the microcapsules prepared from the multi-component composite exhibited a normal distribution, wherein the microcapsules prepared from the quaternary composite emulsion exhibited a unimodal distribution in which one peak represented the major dimension and the microcapsule powder particle size was in the range of 5 to 10 μm, the median diameter was 7.355 μm, and the particle size distribution was uniform. Compared with the particle size distribution curve of the quaternary composite microcapsule, the particle size distribution curve of the microcapsule prepared by the ternary composite emulsion is more dispersed, and the median diameter is 7.455um.
2.3 DSC analysis of microcapsules
Accurately weighing a certain amount of sample by using tweezers, putting the sample into a crucible flatly, sealing by using a press, and putting the sample into DSC for measurement. Wherein the temperature rising rate of DSC is 10 ℃/min, the scanning temperature range is 30-340 ℃, and the flow rate of nitrogen is 20m L/min. The maltodextrin-soy protein isolate-alpha-lactalbumin ternary complex wall omega 3 fatty acid microcapsule and the maltodextrin-soy protein isolate-alpha-lactalbumin quaternary complex wall omega 3 fatty acid microcapsule are scanned by DSC respectively, and a differential scanning analysis curve is made.
The DSC analyzer can accurately measure the melting point, melting enthalpy, crystallization temperature, crystallization melting heat and the like of the microcapsule, thereby reflecting the heat stability of the microcapsule product.
FIG. 10 is a DSC of a microcapsule. Wherein (a) is a DSC profile of a ternary complex microcapsule; (b) is a DSC of a quaternary complex microcapsule.
As can be seen in fig. 10, the ternary composite microcapsules prepared from the α -la+md+spi composite wall material underwent a glass transition at 85.27 ℃; the quaternary composite microcapsule prepared by the alpha-LA+MD+SPI+Cur composite wall material has glass transition at 80.72 ℃; at this temperature (glass transition temperature), the stiffness and viscosity of some of the ingredients in the microcapsule product begin to decrease and the elasticity increases. It is thus shown that the structure of the microcapsules remains intact during conventional heat treatment. The mass loss of the two DSC curves at 100 ℃ is probably caused by the evaporation of water, and the remarkable mass loss occurs at 100-200 ℃, which is probably caused by the decomposition of the wall material, and the oil sample is exposed to a high-temperature environment along with the cracking of the wall material in the range of 200-320 ℃, so that the peony seed oil and fish oil composite oil and the wall material are further pyrolyzed. As can be seen from fig. 10, the cracking rate of the quaternary compound microcapsules is slightly lower than that of the ternary compound microcapsules, indicating that the combination of the wall materials in the quaternary compound microcapsules can better slow down the cracking rate of the compound oil.
2.4 FT-IR analysis of microcapsules
The FT-IR is used to characterize the microcapsules, and the formation of the microcapsules is mainly judged according to the shape, displacement and intensity changes of characteristic peaks of core material molecules before and after microencapsulation.
Respectively weighing a certain amount of maltodextrin, alpha-lactalbumin, soy protein isolate, curcumin, peony seed oil, fish oil, peony seed oil and fish oil blend oil, ternary composite wall microcapsule and quaternary composite microcapsule sample added with curcumin, mixing according to the mass ratio of the sample to potassium bromide of 1:50-1:200, fully grinding in an agate mortar, taking out and pressing into transparent slices. At 400-4000 cm -1 And (3) carrying out infrared wavelength scanning on the sample within the range of (1) and analyzing the measurement result.
As shown in fig. 11-13, the infrared spectra of four wall material, peony seed oil, fish oil, complex oil and microcapsule powder samples are shown. MD, alpha-LA and SPI at 3428.70cm -1 、3306.09cm -1 And 3345.22cm -1 The maximum absorption peaks are respectively arranged at the positions, and are caused by the telescopic vibration of-OH; at 2800-3100 cm -1 The peony seed oil and fish oil compound oil has strong bond stretching vibration of C=C conjugated double bonds between wavelengths; at 1743.48cm -1 The higher intensity c=o absorption peak appeared in the complex oil sample. In FIG. 13, 2800 to 3100cm in ternary complex microcapsules and quaternary complex microcapsules -1 C=c absorption peak at and 1743.48cm -1 The C=O absorption peak at the position is obviously weakened, which indicates that the characteristic absorption peak in the peony seed oil, the fish oil and the compound oil can be well covered by the wall material, which further verifies the microCapsule formation.
2.5 XRD analysis of microcapsules
X-ray diffraction phase analysis is a technique for analyzing a substance structure by utilizing the diffraction effect of X-rays in a crystalline substance. The microcapsules were characterized using an X-ray diffractometer. Uniformly tiling the prepared microcapsule sample, wherein the scanning angle 2 theta is 10-80.
As shown in fig. 14, the microcapsules showed strong diffraction peaks at 2θ=19.6°, and the crystallinity increased, indicating that the microcapsules produced aggregated particles at this time.
2.6 fatty acid composition analysis of Complex oils before and after microencapsulation
2.6.1 extraction of oil from microcapsules
100mg of the sample was weighed precisely into a clean inlet EP tube, 4ml of chloroform was added, and the mixture was vortexed for 30s to mix. Centrifuging at 3500rpm at room temperature for 15min, taking out and standing. The lower liquid was sucked up by an automatic pipette and transferred to another test tube. 2ml of dichloromethane was added thereto, and the mixture was vortexed for 30s and centrifuged for 15min to remove the lower layer. The lower liquid was combined (twice extractions) and blow-dried with nitrogen.
2.6.2 derivatization of oils and fats in microcapsules
After nitrogen blow-down, 2ml of methylating agent was added and vortexed for 30s, water-bath at 80℃for 2h. The bottle mouth part is covered by low-temperature gauze during the water bath to prevent gas from being dispersed. After cooling in the water bath, 2ml of n-hexane and 1ml of water were added, and the mixture was centrifuged at 2000rpm for 5min with 30s of vortex. Adding 1ml of water into the supernatant, swirling for 30s, centrifuging at 2000rpm for 5min, taking supernatant nitrogen and drying. Adding isooctane with proper volume according to the concentration of the sample, swirling for 30s, standing for 5min, transferring the solution to a sample injection bottle, and waiting for detection.
2.6.3 chromatographic parameters
The chromatographic system adopts an Agilent meteorological chromatographic system (Agilent 6890;Agilent Technologies,USA), and adopts a CP-Sil 88 (100 m multiplied by 0.25mm multiplied by 0.25 mu m) gas chromatographic column according to the properties of the compound, wherein the sample injection amount is 1ul, and the split ratio is 10:1, the carrier gas is high-purity helium with the flow rate of 1.0ml/min; the initial temperature of the column oven is kept at 100 ℃ for 5.0min, and the temperature is programmed to 240 ℃ at 4 ℃/min for 15min.
2.6.4 Mass Spectrometry parameters
The mass spectrometry system used was a quadrupole mass spectrometry detection system (Agilent 5977; agilent Technologies, USA) from aigle corporation, USA, equipped with an electron-bombarded ion source (EI) and a MassHunter workstation. The analyte is detected in a full SCAN (SCAN) mode using an electron bombardment ion source (EI). The optimized mass spectrometry conditions were as follows: the temperature of the sample inlet is 260 ℃ and the temperature of the quaternary rod is 150 ℃; the scanning mode is a full scanning mode (SCAN), and the quality scanning range (m/z): 30-550.
2.6.5 fatty acid composition analysis of Complex oils before and after microencapsulation
TABLE 6 variation of fatty acid composition of compound oils and fats before and after spray drying
As is clear from fig. 15 and table 6, the compound oil obtained mainly has 9 kinds of fatty acids, the carbon chain length is between C14 and C22, and the unsaturated fatty acid content is very rich, and the compound oil includes not only monounsaturated fatty acids (MUFA) such as oleic acid, eicosenoic acid, palmitoleic acid, and the like, but also polyunsaturated fatty acids (PUFA) such as linolenic acid and linoleic acid, and the like. At the same time, small amounts of Saturated Fatty Acids (SFA) are also present, mainly palmitic acid, stearic acid, arachidic acid, myristic acid, behenic acid, etc. The composite oil microcapsule prepared by adopting a spray drying method has no damage to the nutritive value of fatty acid of the composite oil although the composite oil microcapsule is subjected to instantaneous high temperature, and has a good protection effect on the core material.
3. Storage stability of microcapsules
3.1, research method
3.1.1 measurement of peroxide value
The measurement and calculation were performed by an acid-base titration method with reference to the method for measuring peroxide value (POV) in GB5009.227-2016 oil.
3.1.2 measurement of DPPH radical scavenging ability
Measurement of DPPH radical scavenging ability the method of reference [1] was used.
[1] Yang Jing extraction of highly active Silybum marianum oil and microencapsulation research [ D ] university of Jiangsu 2020.DOI:10.27170/d.cnki. Gjsuu 2020.001899.
3.2 measurement of peroxide value
In the food industry, the trend of change in POV value is an important indicator of how oxidized the grease is during storage. This parameter is obtained by measuring the amount of hydroperoxide in the oil, which is formed by the reaction between oxygen and unsaturated fatty acids. The oxidative stability of the powder is strongly influenced by the combination of wall materials. The oxidation stability of the microencapsulated oils was evaluated under accelerated storage conditions.
TABLE 7 oxidative stability of complex oils, ternary complex microcapsules and quaternary complex microcapsules
As can be seen from the data in FIG. 16 and Table 7, the POV initial values of the complex oil, ternary complex microcapsule and quaternary complex microcapsule were 7.432mmol/kg, 2.012mmol/kg and 1.434mmol/kg, respectively. The POV values of the compound oil and the compound oil microcapsules are increased along with the extension of the storage time, and the oxidation speed of the microcapsules for accelerating the oxidation storage under the condition of 42 ℃ is obviously higher than that of the microcapsules for storing at 22 ℃, so that the compound oil microcapsules are prevented from being in a high-temperature environment as much as possible in the storage process.
The POV values of the compound oil, the ternary complex microcapsule and the quaternary complex microcapsule reach 33.582mmol/kg, 7.277mmol/kg and 6.953mmol/kg after 12 days of storage at the room temperature, and the POV values of the compound oil, the ternary complex microcapsule and the quaternary complex microcapsule reach 127.5mmol/kg, 26.853mmol/kg and 17.275mmol/kg after 12 days of accelerated storage at 42 ℃.
The POV value change of the composite oil microcapsule under the storage condition of 22 ℃ is compared with that of the composite oil, and the POV value of the composite oil is found to be obviously higher than that of the composite oil microcapsule, so that the composite wall material has a good embedding effect on the composite oil, and the oxidation rate of the peony seed oil in the microcapsule can be effectively reduced. The POV value of the quaternary composite microcapsule prepared from the quaternary composite wall material (alpha-LA+MD+SPI+Cur) at 42 ℃ is obviously lower than that of the ternary composite microcapsule, which further indicates that the quaternary composite wall material (alpha-LA+MD+SPI+Cur) has good antioxidation effect.
3.3 measurement of DPPH
As can be seen from fig. 17, at greater than 8mg/mL, ternary complex microcapsule DPPH radical scavenging rate decreased, quaternary complex microcapsule DPPH radical scavenging rate increased, and eventually significantly higher than ternary complex microcapsule.
The foregoing description of the preferred embodiments of the invention is not intended to be limiting, but rather is intended to cover all modifications, equivalents, and alternatives falling within the spirit and principles of the invention.
Claims (5)
1. The quaternary compound microcapsule for carrying the enriched omega 3 fatty acid is prepared from a core material and a wall material, and is characterized in that the core material is blend oil containing the omega 3 fatty acid, and the wall material is prepared from a ternary compound and a functional factor; the ternary complex is prepared from maltodextrin, soy protein isolate and alpha-lactalbumin; the functional factor is curcumin;
in the ternary complex, the mass ratio of maltodextrin, soy protein isolate and alpha-lactalbumin is 1: 1-2: 1 to 3;
the mass ratio of the ternary complex to the curcumin is 30:0.01;
the mass ratio of the wall material to the core material is 6-7: 5, a step of;
the process for preparing the quaternary composite microcapsule also comprises spray drying, wherein the spray drying conditions are as follows: the air inlet temperature is 160-180 ℃, and the feeding flow rate is 16-18 mL/min.
2. A method of preparing the quaternary complex microcapsules carrying enriched omega 3 fatty acids of claim 1, comprising the steps of:
s1, adding maltodextrin, soy protein isolate and alpha-lactalbumin into water at 50-55 ℃, stirring and mixing, adding a curcumin solution, continuously stirring and mixing, adding a core material, and uniformly stirring to obtain a primary emulsion;
s2, shearing and stirring the primary emulsion of the S1 at 50-55 ℃, then placing the primary emulsion in a high-pressure homogenizer for high-pressure homogenization treatment, and carrying out spray drying to obtain the quaternary composite microcapsule carrying the enriched omega 3 fatty acid.
3. The method of claim 2, wherein the curcumin solution is prepared by dissolving curcumin in ethanol; the dosage ratio of curcumin to ethanol is 0.01g: 4-6 mL.
4. The method for preparing quaternary complex microcapsules carrying enriched omega 3 fatty acids according to claim 2, wherein in S2, the shearing and stirring conditions are 8000-9600 r/min.
5. The method for preparing quaternary complex microcapsules carrying enriched omega 3 fatty acids according to claim 2, wherein in S2, the high pressure homogenizing pressure is 30-35 Mpa.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202211226748.4A CN115590191B (en) | 2022-10-09 | 2022-10-09 | Quaternary complex microcapsule carrying enriched omega 3 fatty acid and preparation method thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202211226748.4A CN115590191B (en) | 2022-10-09 | 2022-10-09 | Quaternary complex microcapsule carrying enriched omega 3 fatty acid and preparation method thereof |
Publications (2)
Publication Number | Publication Date |
---|---|
CN115590191A CN115590191A (en) | 2023-01-13 |
CN115590191B true CN115590191B (en) | 2024-02-27 |
Family
ID=84846631
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202211226748.4A Active CN115590191B (en) | 2022-10-09 | 2022-10-09 | Quaternary complex microcapsule carrying enriched omega 3 fatty acid and preparation method thereof |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN115590191B (en) |
Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102871142A (en) * | 2012-10-17 | 2013-01-16 | 青岛农业大学 | Goose fatty liver oil microcapsule |
CN107518094A (en) * | 2017-10-13 | 2017-12-29 | 广东金妮宝科技发展有限公司 | The preparation method and camellia seed oil capsule powders of a kind of camellia seed oil microscapsule powder |
CN110179118A (en) * | 2019-07-01 | 2019-08-30 | 佳格食品(厦门)有限公司 | A kind of sunflower seeds nutrient blend oil microcapsules and preparation method thereof suitable for infant |
CN111659328A (en) * | 2020-05-14 | 2020-09-15 | 浙江工业大学 | Preparation process of linseed oil microcapsule and product thereof |
AU2020102945A4 (en) * | 2020-10-21 | 2020-12-17 | Beijing Health Information Medical Technology Inc. | Compound oil microcapsule with reasonable fatty acid proportion and high stability and its preparation method thereof |
CN114468298A (en) * | 2022-02-10 | 2022-05-13 | 山东四季园牡丹生物科技有限公司 | Peony seed oil microcapsule and preparation method thereof |
-
2022
- 2022-10-09 CN CN202211226748.4A patent/CN115590191B/en active Active
Patent Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102871142A (en) * | 2012-10-17 | 2013-01-16 | 青岛农业大学 | Goose fatty liver oil microcapsule |
CN107518094A (en) * | 2017-10-13 | 2017-12-29 | 广东金妮宝科技发展有限公司 | The preparation method and camellia seed oil capsule powders of a kind of camellia seed oil microscapsule powder |
CN110179118A (en) * | 2019-07-01 | 2019-08-30 | 佳格食品(厦门)有限公司 | A kind of sunflower seeds nutrient blend oil microcapsules and preparation method thereof suitable for infant |
CN111659328A (en) * | 2020-05-14 | 2020-09-15 | 浙江工业大学 | Preparation process of linseed oil microcapsule and product thereof |
AU2020102945A4 (en) * | 2020-10-21 | 2020-12-17 | Beijing Health Information Medical Technology Inc. | Compound oil microcapsule with reasonable fatty acid proportion and high stability and its preparation method thereof |
CN114468298A (en) * | 2022-02-10 | 2022-05-13 | 山东四季园牡丹生物科技有限公司 | Peony seed oil microcapsule and preparation method thereof |
Non-Patent Citations (2)
Title |
---|
以大豆蛋白制备微胶囊化鱼油的研究(Ⅰ)――微胶囊化鱼油的壁材选择;朱迅涛, 许时婴;中国油脂(05);全文 * |
刘程等.当代新型食品.北京工业大学出版社,1998,第456页. * |
Also Published As
Publication number | Publication date |
---|---|
CN115590191A (en) | 2023-01-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN105876792B (en) | A kind of preparation method of novel beta carotene microcapsules | |
DE60309684T2 (en) | Encapsulated attachment of microcapsules and their preparation | |
CA2145171C (en) | Product and process of making microcrystalline cellulose | |
Bai et al. | Development and characterization of soybean oil microcapsules employing kafirin and sodium caseinate as wall materials | |
WO2008017962A2 (en) | Microcapsules with improved shells | |
CN107484985B (en) | Self-emulsifying fish oil microcapsule and production process thereof | |
Drozińska et al. | Microencapsulation of sea buckthorn oil with β-glucan from barley as coating material | |
Tolve et al. | Preparation and characterization of microencapsulated phytosterols for the formulation of functional foods: Scale up from laboratory to semi-technical production | |
CN114271499A (en) | Microcapsule powder with high embedding rate and preparation method thereof | |
US20090214661A1 (en) | Process for the production of beadlets | |
CN111436500A (en) | Method for preparing perilla seed oil microcapsules by adding corn oligopeptide | |
Xu et al. | Microencapsulation of sea buckthorn (Hippophae rhamnoides L.) pulp oil by spray drying | |
CZ306182B6 (en) | Soft tablet for bouillon preparation | |
CN113698673B (en) | Preparation method of modified starch-lipid binary compound | |
Onsaard et al. | Microencapsulated vegetable oil powder | |
CN115590191B (en) | Quaternary complex microcapsule carrying enriched omega 3 fatty acid and preparation method thereof | |
CN101390588B (en) | Grease microcapsule prepared by high-pressure homogeneous modification rice starch and method thereof | |
KR100810868B1 (en) | Microencapsulation processing method of omaga-3 fatty acid, method for making the food and food | |
US20230320398A1 (en) | Stabilized vitamin a and method of production | |
CN114431471A (en) | Oil microcapsule powder, preparation method and application | |
CN112075630A (en) | Natural carotene microcapsule and preparation method thereof | |
CN110547457A (en) | Polyunsaturated fatty acid microcapsule and preparation method and application thereof | |
Tang et al. | Enhancing stability of 1, 3-dioleic acid-2-palmitate (OPO) through microencapsulation: A comparative study of single-and double-layer microcapsules | |
Ogrodowska et al. | Native and pregelatinized potato and rice starches and maltodextrin as encapsulating agents for linseed oil ethyl esters–Comparison of emulsion and powder properties | |
CN113974165A (en) | Microcapsule containing polyunsaturated fatty acid grease and preparation method and application thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant |